Restore a 9 mm diameter osteochondral defect with gene enhanced tissue engineering followed mosaicplasty in a goat model

Objective: The aim of this study was to evaluate the efŞcacy of gene enhanced tissue engineering followed mosaicplasty in a goat model.Methods: An acute cylindrical defect 9 mm in diameter was created in the weight bearing area of themedial femoral condyle in a goat model. Thirty-six medial femoral condyles were divided into 6 groupsusing different proportion of gene enhanced tissue engineering and mosaicplasty to restore the defects.The specimen received gross and histology observation, which was evaluated by the histological gradingscale of O'Driscoll, Keeley and Salter. Transmission electron microscope observation was also performed.Two factors analysis of variance and Student-Newman-Kewls test were used to compare the specimen.Results: The gross and histology observation revealed that each defects of six groups had differentrestoration. The scores of the reparative tissue of three groups with gene enhancement were signiŞcantlyhigher than those in other three groups without gene enhancement (p> 0.05).Conclusion: Gene enhanced tissue engineering followed mosaicplasty could restore a 9 mm diameterosteochondral defects in a goat model effectively. With the reduction of covering area of the graft, theadvantages of the combined gene enhanced tissue engineering method can be better reflected.© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This isan open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

___

Emre TY, Ege T, Kose O, Tekdos Demırcıoglu D, Seyhan B, Uzun M. Factors affecting the outcome of osteochondral autografting (mosaicplasty) in articular cartilage defects of the knee joint: retrospective analysis of 152 cases. Arch Orthop Trauma Surg. 2013 Apr;133:531e536.

Berta A, Duska Z, T oth F, Hangody L. Clinical experiences with cartilage repair techniques: outcomes, indications, contraindications and rehabilitation. Eklem Hast Cerrahisi. 2015;26:84e96.

Hangody L, Kish G, K arp ati Z, Udvarhelyi I, Szigeti I, B ely M. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics. 1998 Jul;21:751e756.

Sun J, Hou XK, Li X, et al. Mosaicplasty associated with gene enhanced tissue engineering for the treatment of acute osteochondral defects in a goat model. Arch Orthop Trauma Surg. 2009 Jun;129:757e771.

O'Driscoll SW, Keeley FW, Salter RB. Durability of regenerated articular carti- lage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J Bone Jt Surg Am. 1988 Apr;70:595e606.

Hangody L, Füles P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Jt Surg Am. 2003;85-A:25e32.

Robert H. Chondral repair of the knee joint using mosaicplasty. Orthop Trau- matol Surg Res. 2011 Jun;97:418e429.

Harris JD, Siston RA, Pan X, Flanigan DC. Autologous chondrocyte implantation: a systematic review. J Bone Jt Surg Am. 2010 Sep 15;92:2220e2233.

Hangody L, V as arhelyi G, Hangody LR, et al. Autologous osteochondral graf- tingetechnique and long-term results. Injury. 2008 Apr;39:S32eS39.

Hangody L, Dobos J, Bal o E, P anics G, Hangody LR, Berkes I. Clinical experiences with autologous osteochondral mosaicplasty in an athletic population: a 17- year prospective multicenter study. Am J Sports Med. 2010 Jun;38:1125e1133. 11. Jakob RP, Franz T, Gautier E, Mainil-Varlet P. Autologous osteochondral grafting in the knee: indication, results, and reflections. Clin Orthop Relat Res. 2002 Aug;401:170e184.

Steinert AF, NEURoth U, Tuan RS. Concepts in gene therapy for cartilage repair. Injury. 2008 Apr;39:S97eS113.

Khan WS, Johnson DS, Hardingham TE. The potential of stem cells in the treatment of knee cartilage defects. Knee. 2010 Dec;17:369e374.

Elmallah RK, Cherian JJ, Jauregui JJ, Pierce TP, Beaver WB, Mont MA. Genetically modiŞed chondrocytes expressing TGF-b1: a revolutionary treatment for articular cartilage damage? Expert Opin Biol Ther. 2015 Mar;15:455e464.

Potier E, Noailly J, Ito K. Directing bone marrow-derived stromal cell function with mechanics. J Biomech. 2010 Mar 22;43:807e817.

Chajra H, Rousseau CF, Cortial D, et al. Collagen-based biomaterials and carti- lage engineering. Application to osteochondral defects. Biomed Mater Eng. 2008;18:S33eS45.

Bidarra SJ, Barrias CC, Granja PL. Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomater. 2014 Apr;10:1646e1662.